Milestone Pharmaceuticals Inc. (MIST): Cash & Equivalents
$73.05M
As of 2025-12-31
$169.73M
As of 2026-06-30
+112.3%
3-year compound annual growth
+0.2%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $73.05M | +188.6% | 2026-03-20, Balance as of period end |
| 2024-12-31 | $25.31M | +84.0% | 2026-03-20, Balance as of period end |
| 2023-12-31 | $13.76M | +80.2% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $7.64M | -93.3% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $114.14M | +57.8% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $72.31M | -39.7% | 2022-03-24, Balance as of period end |
| 2019-12-31 | $119.82M | +39.4% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $85.95M | n/a | 2020-10-23, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $73.05M | +188.6% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $21.82M | -60.8% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $52.77M | n/m |
| Rezolute, Inc. (RZLT) | 2026-06-30 | $10.62M | -88.7% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $35.02M | -53.8% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $37.98M | -7.1% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $47.05M | -23.7% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $109.52M | +71.0% |
Compare MIST, KRRO, RFL, RZLT side by side · Screen every company in Pharmaceutical Preparations ↗